Global In-Vitro Diagnostic Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In-Vitro Diagnostic Market Research Report 2024
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
According to MRAResearch’s new survey, global In-Vitro Diagnostic market is projected to reach US$ 91350 million in 2033, increasing from US$ 64460 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostic market research.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 28% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott
Johnson and Johnson
BD
Danaher
Thermo Fisher Scientific
Bio-Rad
Hologic
KEM-EN-TEC Diagnostics
Medtronic
Omega Diagnostics
Ortho Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex
Atlas Genetics
ELITechGroup
Biomerieux
Werfen
Segment by Type
Test Equipment
Test Reagents
Hospitals and Clinics
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In-Vitro Diagnostic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global In-Vitro Diagnostic market is projected to reach US$ 91350 million in 2033, increasing from US$ 64460 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostic market research.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 28% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Johnson and Johnson
BD
Danaher
Thermo Fisher Scientific
Bio-Rad
Hologic
KEM-EN-TEC Diagnostics
Medtronic
Omega Diagnostics
Ortho Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex
Atlas Genetics
ELITechGroup
Biomerieux
Werfen
Segment by Type
Test Equipment
Test Reagents
Segment by Application
Hospitals and Clinics
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In-Vitro Diagnostic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source